WhiteLab Genomics · May 2026
Company reported ~50x higher DNA enrichment in the brain versus AAV9 after IV injection in mice, with undetectable liver signal, and positioned the ALFRED platform for neurological genomic medicine.
Unleashing the potential of DNA and RNA based therapies using AI
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
WhiteLab Genomics is a Paris-area TechBio company founded in 2019 that uses its ALFRED AI platform to design and optimize genomic medicine components—especially viral and non-viral vectors, payloads, and bioproduction workflows—through a co-development model with pharma, biotech, and academic partners.
Primary product
ALFRED AI platform for genomic medicine design and optimization
Founded
2019
Headquarters
Évry-Courcouronnes, Île-de-France, France
Team size
11-50
Work style
Hybrid
Industry
Biotechnology Research
Sub-industry
TechBio / AI for genomic medicine
Offices
Open Positions
0 jobs at WhiteLab Genomics
No open positions
Check back later for new openings